AUG 13, 2026 · PHASE EARLY PHASE 1 TRIAL
A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity
ClinicalTrials.gov
This is a first-in-human Phase 1 trial registration with no results posted; it is early-stage safety and pharmacokinetic work designed to establish initial tolerability and drug behavior.
Reported
Planned enrollment88
PhaseEARLY_PHASE1
Study armsZP6590 (ascending doses) vs placebo